| Galectin-3: one molecule for an alphabet of diseases, from A to Z S Sciacchitano, L Lavra, A Morgante, A Ulivieri, F Magi, GP De Francesco, ... International journal of molecular sciences 19 (2), 379, 2018 | 389 | 2018 |
| Repression of the antiapoptotic molecule galectin-3 by homeodomain-interacting protein kinase 2-activated p53 is required for p53-induced apoptosis B Cecchinelli, L Lavra, C Rinaldo, S Iacovelli, A Gurtner, A Gasbarri, ... Molecular and cellular biology 26 (12), 4746-4757, 2006 | 138 | 2006 |
| More than apples and oranges-Detecting cancer with a fruit fly's antenna M Strauch, A Lüdke, D Münch, T Laudes, CG Galizia, E Martinelli, L Lavra, ... Scientific reports 4 (1), 3576, 2014 | 93 | 2014 |
| Investigation of VOCs associated with different characteristics of breast cancer cells L Lavra, A Catini, A Ulivieri, R Capuano, L Baghernajad Salehi, ... Scientific reports 5 (1), 13246, 2015 | 91 | 2015 |
| The loss of the p53 activator HIPK2 is responsible for galectin-3 overexpression in well differentiated thyroid carcinomas L Lavra, C Rinaldo, A Ulivieri, E Luciani, P Fidanza, L Giacomelli, ... PLoS One 6 (6), e20665, 2011 | 76 | 2011 |
| Comparative analysis of diagnostic performance, feasibility and cost of different test-methods for thyroid nodules with indeterminate cytology S Sciacchitano, L Lavra, A Ulivieri, F Magi, GP De Francesco, C Bellotti, ... Oncotarget 8 (30), 49421, 2017 | 60 | 2017 |
| Homeodomain‐interacting protein kinase2 in human idiopathic pulmonary fibrosis A Ricci, E Cherubini, A Ulivieri, L Lavra, S Sciacchitano, D Scozzi, ... Journal of cellular physiology 228 (1), 235-241, 2013 | 46 | 2013 |
| Gal‐3 is stimulated by gain‐of‐function p53 mutations and modulates chemoresistance in anaplastic thyroid carcinomas L Lavra, A Ulivieri, C Rinaldo, R Dominici, M Volante, E Luciani, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2009 | 46 | 2009 |
| Antiproliferative Effects of 1α-OH-vitD3 in Malignant Melanoma: Potential Therapeutic implications L Spath, A Ulivieri, L Lavra, L Fidanza, M Carlesimo, M Giubettini, ... Scientific reports 7 (1), 40370, 2017 | 30 | 2017 |
| Clinico-pathological significance of cell-type-specific loss of heterozygosity on chromosome 7q21: analysis of 318 microdissected thyroid lesions. M Trovato, A Ulivieri, R Dominici, RM Ruggeri, E Vitarelli, S Benvenga, ... Endocrine-related cancer 11 (2), 365-376, 2004 | 24 | 2004 |
| Frizzled‐1 is down‐regulated in follicular thyroid tumours and modulates growth and invasiveness A Ulivieri, L Lavra, R Dominici, L Giacomelli, E Brunetti, L Sciacca, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2008 | 23 | 2008 |
| Expression of p53/hgf/c-met/STAT3 signal in fetuses with neural tube defects M Trovato, M D’Armiento, L Lavra, A Ulivieri, R Dominici, E Vitarelli, ... Virchows Archiv 450, 203-210, 2007 | 20 | 2007 |
| Combined clinical and ultrasound follow-up assists in malignancy detection in Galectin-3 negative Thy-3 thyroid nodules S Sciacchitano, L Lavra, A Ulivieri, F Magi, T Porcelli, S Amendola, ... Endocrine 54, 139-147, 2016 | 13 | 2016 |
| Nonthyroidal illness syndrome (NTIS) in severe COVID-19 patients: role of T3 on the Na/K pump gene expression and on hydroelectrolytic equilibrium S Sciacchitano, C Capalbo, C Napoli, A Negro, L De Biase, A Marcolongo, ... Journal of translational medicine 19, 1-18, 2021 | 11 | 2021 |
| Molecular characterization of a selected cohort of patients affected by pulmonary metastases of malignant melanoma: Hints from BRAF, NRAS and EGFR evaluation A Ulivieri, G Cardillo, L Manente, G Paone, AP Mancuso, L Vigna, ... Oncotarget 6 (23), 19868, 2015 | 11 | 2015 |
| Thyroid hormones regulate cardiac repolarization and QT-interval related gene expression in hiPSC cardiomyocytes A Ulivieri, L Lavra, F Magi, A Morgante, L Calò, P Polisca, LB Salehi, ... Scientific Reports 12 (1), 568, 2022 | 8 | 2022 |
| Generation and characterization of the human induced pluripotent stem cell (hiPSC) line NCUFi001-A from a patient carrying KCNQ1 G314S mutation L Lavra, F Magi, A Ulivieri, A Morgante, M Paulis, L Sala, M Pedrazzini, ... Stem Cell Research 54, 102418, 2021 | 2 | 2021 |
| Retrospective analysis of seroprevalence in a cohort of university students of Rome (Italy) between September 2020 and July 2021. A Ulivieri, A Morgante, F Magi, LB Salehi, L Lavra Epidemiologia e Prevenzione 46 (5-6), 367-375, 2022 | 1 | 2022 |
| Analysis of the role of p53 and galectin-3 in proliferation and apoptosis of thyroid carcinoma cell lines by specific RNA interference experiments L Lavra, A Ulivieri, R Dominici, M Trovato, A Bartolazzi, S Soddu, ... BIOMÉDECINE & PHARMACOTHÉRAPIE 60 (8), 491-491, 2006 | 1 | 2006 |
| LOH analysis at 7q32-34 in Papillary Thyroid Carcinomas reveals a new apoptotic pathway involving HIPK2, p53, and galectin-3 B Cecchinelli, A Ulivieri, C Rinaldo, A Gasbarri, L Lavra, F DEL PRETE, ... 76th Annual Meeting of the American Thyroid Association (ATA) 14, 2004 | 1 | 2004 |
